Related Experiment Videos

Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats

Neuroendocrinology
|January 1, 1978
PubMed

Insights

Dopamine (DA) neurons in the hypothalamus tonically inhibit MSH release from the pituitary. Blocking DA receptors or lesioning hypothalamic connections reduces MSH, while DA agonists prevent this reduction.

Area of Science:

  • Neuroendocrinology
  • Dopaminergic signaling
  • Pituitary hormone regulation

Background:

  • The pars intermedia of the pituitary releases melanocyte-stimulating hormone (MSH).
  • The physiological role of dopaminergic innervation to the pars intermedia is not fully understood.

Purpose of the Study:

  • To investigate the role of dopaminergic innervation in regulating pituitary MSH content and release.

Main Methods:

  • Rats underwent electrothermic lesions in the mediobasal hypothalamus to disrupt hypothalamo-hypophysial connections.
  • Neuroleptics (haloperidol, pimozide) were used to block dopamine receptors.
  • Dopamine receptor agonists (apomorphine, 2-Br-alpha-ergocryptine) were administered.

Main Results:

  • Hypothalamic lesions significantly decreased pituitary MSH content.
  • Dopamine receptor blockade by neuroleptics also reduced MSH levels.
  • Dopamine receptor agonists prevented the MSH decrease caused by lesions.

Conclusions:

  • Dopaminergic neurotransmission within the pituitary controls MSH release.
  • Dopaminergic arcuato-hypophysial neurons tonically inhibit MSH release in intact rats.

Related Concept Videos